Drug intelligence / Profile preview

Duzhibao

Development stage
Unknown
Lead developer
Shanghai Fengxian District Central Hospital
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Duzhibao (also referred to as Zu zhibao in clinical registry records) is an oral liquid formulation, likely a botanical extract or Traditional Chinese Medicine (TCM) product, currently being investigated for its potential to modulate postprandial blood glucose and insulin levels. It is being evaluated in a clinical trial (ChiCTR2500102977) sponsored by Shanghai Fengxian Central Hospital, which focuses on adults with type 2 diabetes mellitus. The study is an acute randomized, placebo-controlled, crossover trial that assesses the immediate effects of the liquid during a mixed meal tolerance test (MMTT). While the specific active ingredients and molecular targets are not disclosed in the registry, the product is positioned as a therapeutic intervention for glycemic management in diabetic patients, potentially through the modulation of glucose absorption or insulin sensitivity.

Brand names
Duzhibao
Other names
Zu zhibao

Beyond the preview

Go deeper on Duzhibao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duzhibao.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call